CLINICAL_TRIALS
ClinicalTrials.gov record update
Effect of Anagliptin and Sitagliptin on Low-density Lipoprotein Cholesterol in Patients With Type 2 Diabetes and Cardiovascular Risk Factors: Randomized Controlled Trial
This page presents selected fields from the linked source record. It does not add a medical interpretation.
Record identity and dates
- Source
- ClinicalTrials.gov
- Source record ID
- NCT02330406
- Title field or adapter rule
- protocolSection.identificationModule.officialTitle
- Ingested At
- 2026-04-28T10:37:35.980265+00:00
- Published At
- 2019-08-28T00:00:00+00:00
- Record Updated At
- 2019-08-28
- Timestamp Basis
- source retrieval time was not retained by the feed adapter
- Date limitation
- source retrieval time was not retained by the feed adapter
Fields recorded by this source
- protocolSection.conditionsModule.conditions
["Dipeptidyl-Peptidase 4 Inhibitors", "LDL Cholesterol", "Glycosylated Hemoglobin", "Diabetes Mellitus", "Coronary Disease"]- protocolSection.statusModule.lastUpdatePostDateStruct.date
"2019-08-28"- protocolSection.identificationModule.nctId
"NCT02330406"- protocolSection.identificationModule.officialTitle
"Effect of Anagliptin and Sitagliptin on Low-density Lipoprotein Cholesterol in Patients With Type 2 Diabetes and Cardiovascular Risk Factors: Randomized Controlled Trial"- protocolSection.statusModule.overallStatus
"COMPLETED"- protocolSection.designModule.phases
["PHASE4"]- protocolSection.statusModule.resultsFirstPostDateStruct.date
""
Study condition terms
Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.
This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.